Navigation Links
Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc.
Date:11/21/2008

Special meeting of shareholders to be held on January 8, 2009

TORONTO, Nov. 21 /PRNewswire-FirstCall/ - Med-Emerg International Inc. ("MedEmerg") (OTCBB: MDER), one of Canada's leading providers of health services, announced today that it has obtained an interim order from the Ontario Superior Court of Justice concerning its previously announced plan of arrangement (the "Arrangement") pursuant to which AIM Health Group Inc. ("AIM") will acquire all of MedEmerg's outstanding shares. Under the Arrangement, holders of MedEmerg common shares will receive 0.78091 of an AIM common share for each MedEmerg common share, subject to adjustment in the case of fractional AIM common shares and Calian Technologies Ltd., the sole holder of Special Shares, Series 1 of MedEmerg, will exchange all of such shares for a secured convertible debenture of AIM. In addition, MedEmerg options will be exchanged for AIM options and MedEmerg warrants will be cancelled.

A special meeting of shareholders, called to approve the Arrangement, will be held on January 8, 2009. Shareholders of record on November 24, 2008 will be entitled to receive notice and vote at the special meeting. MedEmerg will mail a management information circular and related meeting materials to shareholders in connection with the special meeting next week. These documents will be filed under MedEmerg's company profile on SEDAR at www.sedar.com.

The Board of Directors of MedEmerg has recommended that MedEmerg shareholders vote in favour of the Arrangement.

About Med-Emerg International Inc.

MedEmerg specializes in the coordination and delivery of health care services in Canada. These services include an integrated chronic pain management program, community-based infusion centers and health human resource management, including physician and nurse staffing.

Med-Emerg's audited revenue for its fiscal year ended December 31, 2007 was approximately US$22 million.

(www.medemerg.com)

Caution Concerning Forward-Looking Statements

Certain statements in this press release are forward-looking statements, including, but not limited to, the timing of the special meeting of shareholders and other statements that are not historical facts. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including MedEmerg's experience and perceptions of historical trends, current conditions and expected future developments, as well as other factors that are believed to be appropriate in the circumstances. Forward-looking statements are provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as "expects", "anticipates", "plans", "believes", "estimates", "intends", "targets", "projects", "forecasts", "seeks", "likely" or negative versions thereof and other similar expressions, or future or conditional verbs such as "may", "will", "should", "would" and "could".

By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusion will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of material factors, many of which are beyond MedEmerg's control, affect operations, performance, achievements and results of MedEmerg that may be expressed or implied by such forward-looking statements and could cause actual results to differ materially from current expectations of estimated or anticipated events or results.

These forward-looking statements are made as of the date of this release and, other than as specifically required by law, MedEmerg assumes no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Additional information about the risks and uncertainties of MedEmerg's business is provided in its disclosure materials filed with the securities regulatory authorities in Canada, available at www.sedar.com.


'/>"/>
SOURCE Med-Emerg International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Med-Emerg International Inc. reports improved income from continuing operations
2. Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013
3. Epocrates Offers International Market Research Panel
4. Accreditation to the International Standards Organization for Quality Management Granted to First U.S. Lab
5. MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
6. Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center
7. UIC joins international research effort to study autism
8. Service Corporation International Increases Share Repurchase Authorization to $150 Million and Declares Quarterly Cash Dividend
9. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
10. Anthem Blue Cross and Blue Shield Introduces International Medical Tourism Pilot Program
11. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... Orlando-based Maximized Living has selected Dr. ... gold in Rio. Under the care of Maximized Living doctors at the London ... unprecedented showing, Maximized Living is sending the largest contingent of elite chiropractors to Rio ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic ... the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for brain ... mood optimization products to the store is just one more way Shamangelic Healing ...
(Date:4/29/2016)... ... April 29, 2016 , ... The ... nation’s productivity, stability, even security. Most importantly, employees are the single most important ... are American workers so unhappy? , Just under half of American workers are ...
(Date:4/29/2016)... ... 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd ... sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers ... and Walk and 1-mile walk were held to increase awareness about Lyme disease ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... BERLIN , April 29, 2016 ... world-leading glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years ... pharmaceutical and biotechnology industries. His last role was at ... Member of the Executive Board. Previously Dr. Zurlo held ...
(Date:4/28/2016)... , April 28, 2016 Research ... "Global Plastic Surgery Products Market 2016-2020" report to ... ) , The global plastic surgery products ... 9.47% during the period 2016-2020. , ,The growing adoption ... to the growth of the market. Lasers are used ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 ... of online consumer insights on healthcare, announced today that ... in their report Cool Vendor in Life Sciences, ... , April 15, 2016.  The report focuses on life-science- ... to gain insight from patients and doctors, confirm medication ...
Breaking Medicine Technology: